jefferies

Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock

WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology…

2 months ago

RadNet, Inc. to Present at the Jefferies Healthcare Services Conference on September 29, 2025

September 26, 2025 06:00 ET  | Source: RadNet, Inc. LOS ANGELES, Sept. 26, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:…

3 months ago